Chemical Week Magazine :: Departments :: Vital Statistics
New Route to Hepatitis Drug
10:08 AM MDT | July 23, 2007 | Chemical Week Editorial Staff
Researchers at Imperial College, part of the University of London, say they have identified a novel synthetic route to produce pegylated interferon, a drug currently produced by Roche to treat hepatitis C. The product developed by the Imperial College researchers would not be covered by Roche’s patent, which covers production of interferon coated with...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee